<p>Immuron Limited announced that it has issued 45.472 million shares at A$0.07910 per share, raising A$3.5 million. This capital raising has exhausted the company’s At-The-Market Facility. The funds will be allocated toward advancing Immuron’s objectives, including ongoing clinical and research initiatives. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuron Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-119806), on December 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

IMRN

<p>Immuron Limited raised A$3.5 million through the sale of 45.472 million shares at A$0.07910 per share. The funds will support clinical and research initiatives. This capital raising has exhausted the company's At-The-Market Facility. The information was published via EDGAR by Immuron Limited and is for informational purposes only.</p>

Immuron Raises A$3.5 Million in Share Sale